53 participants
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-10-16
- Start Date:
- 2017-09-29
- Completion:
- 2020-05-04
Conditions
- Neoplasms
Interventions
- DRUG
- BIOLOGICAL